Abstract

Simple SummaryMonitoring and controlling the temperature distribution combined with precise energy delivery are key components for hyperthermia treatment success. Magnetic resonance (MR) imaging is used clinically to monitor the temperature of the treated volume non-invasively. However, there are no comprehensive systematic studies on MR thermometry accuracy during deep pelvic hyperthermia, and the few investigational studies suffer from a high probability of bias due to lacking objective criteria for data inclusion. This study presents the first systematic analysis and defines an imaging-based criterion for prospective patient selection to standardize clinical MR thermometry accuracy assessments.The efficacy of a hyperthermia treatment depends on the delivery of well-controlled heating; hence, accurate temperature monitoring is essential for ensuring effective treatment. For deep pelvic hyperthermia, there are no comprehensive and systematic reports on MR thermometry. Moreover, data inclusion generally lacks objective selection criteria leading to a high probability of bias when comparing results. Herein, we studied whether imaging-based data inclusion predicts accuracy and could serve as a tool for prospective patient selection. The accuracy of the MR thermometry in patients with locally advanced cervical cancer was benchmarked against intraluminal temperature. We found that gastrointestinal air motion at the start of the treatment, quantified by the Jaccard similarity coefficient, was a good predictor for MR thermometry accuracy. The results for the group that was selected for low gastrointestinal air motion improved compared to the results for all patients by 50% (accuracy), 26% (precision), and 80% (bias). We found an average MR thermometry accuracy of 2.0 °C when all patients were considered and 1.0 °C for the selected group. These results serve as the basis for comprehensive benchmarking of novel technologies. The Jaccard similarity coefficient also has good potential to prospectively determine in which patients the MR thermometry will be valuable.

Highlights

  • Introduction conditions of the Creative CommonsSeveral randomized clinical studies have shown the benefit of hyperthermia as a sensitizing agent for chemotherapy and/or radiotherapy [1,2,3,4,5,6,7,8]

  • We presented and validated a selection criterion based on an imaging parameter that can be used prospectively to ensure reliable Magnetic resonance (MR)-thermometry measurements

  • Our analysis showed that gastrointestinal air motion was predictive for MR thermometry accuracy (AUC = 0.91)

Read more

Summary

Introduction

Several randomized clinical studies have shown the benefit of hyperthermia as a sensitizing agent for chemotherapy and/or radiotherapy [1,2,3,4,5,6,7,8]. This study suggests that the quality of hyperthermia treatment delivery is crucial to its clinical success. The 3D temperature distribution knowledge, supplemented with equipment that facilitates precise and adaptive delivery, is critical for improving treatment outcome [10,11,12]. Magnetic resonance (MR)-guided hyperthermia is considered the most promising technological platform to monitor the tumor and healthy tissue temperature non-invasively for real-time dose-optimization and dosimetry in multi-institution clinical trials [13,14,15,16,17]. This is crucial for deciding on clinical acceptance and for benchmarking technology improvements

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call